Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care.
Gjesing A, Schou M, Torp-Pedersen C, Køber L, Gustafsson F, Hildebrandt P, Videbæk L, Wiggers H, Demant M, Charlot M, Gislason GH. Gjesing A, et al. Among authors: wiggers h. Eur J Heart Fail. 2013 Jun;15(6):671-8. doi: 10.1093/eurjhf/hft011. Epub 2013 Feb 8. Eur J Heart Fail. 2013. PMID: 23397577 Free article.
A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study).
Jorsal A, Wiggers H, Holmager P, Nilsson B, Nielsen R, Boesgaard TW, Kumme A, Møller JE, Videbæk L, Kistorp C, Gustafsson I, Tarnow L, Flyvbjerg A. Jorsal A, et al. Among authors: wiggers h. BMJ Open. 2014 May 20;4(5):e004885. doi: 10.1136/bmjopen-2014-004885. BMJ Open. 2014. PMID: 24844271 Free PMC article. Clinical Trial.
Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hänselmann A, Nilsson B, Møller JE, Hjort J, Rasmussen J, Boesgaard TW, Schou M, Videbaek L, Gustafsson I, Flyvbjerg A, Wiggers H, Tarnow L. Jorsal A, et al. Among authors: wiggers h. Eur J Heart Fail. 2017 Jan;19(1):69-77. doi: 10.1002/ejhf.657. Epub 2016 Oct 28. Eur J Heart Fail. 2017. PMID: 27790809 Free article. Clinical Trial.
Risk Models for Prediction of Implantable Cardioverter-Defibrillator Benefit: Insights From the DANISH Trial.
Kristensen SL, Levy WC, Shadman R, Nielsen JC, Haarbo J, Videbæk L, Bruun NE, Eiskjær H, Wiggers H, Brandes A, Thøgersen AM, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, Signorovitch J, Køber L, Thune JJ. Kristensen SL, et al. Among authors: wiggers h. JACC Heart Fail. 2019 Aug;7(8):717-724. doi: 10.1016/j.jchf.2019.03.019. Epub 2019 Jul 10. JACC Heart Fail. 2019. PMID: 31302052 Free article.
Heart rate increases in liraglutide treated chronic heart failure patients: association with clinical parameters and adverse events.
Tougaard RS, Jorsal A, Tarnow L, Hansson NH, Kistorp C, Schou M, Nielsen R, Flyvbjerg A, Videbaek L, Mølgaard H, Nielsen JC, Gustafsson I, Wiggers H. Tougaard RS, et al. Among authors: wiggers h. Scand Cardiovasc J. 2020 Oct;54(5):294-299. doi: 10.1080/14017431.2020.1751873. Epub 2020 Apr 15. Scand Cardiovasc J. 2020. PMID: 32292074 Free article. Clinical Trial.
The impact of the glucagon-like peptide-1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetes.
Nielsen R, Jorsal A, Tougaard RS, Rasmussen JJ, Schou M, Videbaek L, Gustafsson I, Faber J, Flyvbjerg A, Wiggers H, Tarnow L, Kistorp C. Nielsen R, et al. Among authors: wiggers h. Diabetes Obes Metab. 2020 Nov;22(11):2141-2150. doi: 10.1111/dom.14135. Epub 2020 Aug 12. Diabetes Obes Metab. 2020. PMID: 32627271 Clinical Trial.
Patient-reported outcomes and medication adherence in patients with heart failure.
Rasmussen AA, Wiggers H, Jensen M, Berg SK, Rasmussen TB, Borregaard B, Thrysoee L, Thorup CB, Mols RE, Larsen SH, Johnsen SP. Rasmussen AA, et al. Among authors: wiggers h. Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):287-295. doi: 10.1093/ehjcvp/pvaa097. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 32761093
184 results